Evidence map›Paper›PMID 29589297›Full record

ArticleEndocrine pathology2018

Clinical Impact of p27

Gozde Sengul Aycicek, Berna Imge Aydogan, Mustafa Sahin, Cevriye Cansız Ersoz, Serpil Dizbay Sak, Nilgun Baskal

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. TRPC3 Is Downregulated in Primary Hyperparathyroidism.International journal of molecular sciences · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Gozde Sengul AycicekDepartment of Internal Medicine, Ankara University Faculty of Medicine, Sihhiye, 06100, Ankara, Turkey. gzdsengul@gmail.com.
Berna Imge AydoganDepartment of Endocrinology and Metabolism, Ankara University Faculty of Medicine, Ankara, Turkey.
Mustafa SahinDepartment of Endocrinology and Metabolism, Ankara University Faculty of Medicine, Ankara, Turkey.
Cevriye Cansız ErsozDepartment of Pathology, Ankara University Faculty of Medicine, Ankara, Turkey.
Serpil Dizbay SakDepartment of Pathology, Ankara University Faculty of Medicine, Ankara, Turkey.
Nilgun BaskalDepartment of Endocrinology and Metabolism, Ankara University Faculty of Medicine, Ankara, Turkey.
Ankara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to investigate the expressions of p27 kinase inhibitory protein 1 (p27

Indexed as

AdenomaAdultAgedBiomarkers, TumorCyclin-Dependent Kinase Inhibitor p27FemaleHumansHyperparathyroidism, PrimaryMaleMiddle AgedParathyroid NeoplasmsReceptors, Calcium-SensingBiomarkers, TumorCASR protein, humanCyclin-Dependent Kinase Inhibitor p27Receptors, Calcium-SensingCaSRp27 Kip1Parathyroid adenomaPrimary hyperparathyroidism

Identifiers

PMID29589297
OpenAlexW2794566859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.